Abbott Laboratories stock trades at EUR 88.79 after Q2 beat
Published on 09/30/2026 at 14:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Abbott Laboratories stock (ISIN US0028241000) was trading at EUR 88.79 at Lang & Schwarz on September 30, 2026, up 0.09 percent from the prior close of EUR 88.71. The latest operating signal is stronger: Q2 2026 revenue reached USD 12.59 billion, a 13.00 percent year-over-year increase.
Q2 revenue reaches USD 12.59 billion
Abbott's quarter ended June 30, 2026, delivered adjusted diluted EPS of USD 1.31, compared with USD 1.26 in the year-earlier period. GAAP diluted EPS was USD 0.53, reflecting specified after-tax charges of USD 1.362 billion.
According to StockTitan on July 16, 2026, comparable sales grew 4.80 percent. Medical Devices led the reported segments with comparable growth of 8.40 percent, while Nutrition declined 3.60 percent.
Guidance points to USD 5.45-5.60
Management raised full-year 2026 adjusted EPS guidance to USD 5.45-5.60 and projected Q3 adjusted EPS of USD 1.38-1.46. The full-year comparable sales outlook stands at 6.50-7.50 percent, giving investors a measurable benchmark for the next report.
The earnings comparison is unusually clear: adjusted EPS of USD 1.31 exceeded the USD 1.28 consensus by USD 0.03, while revenue of USD 12.59 billion topped the USD 12.52 billion estimate. Those figures place execution, rather than headline growth alone, at the center of the Abbott investment case.
TD Cowen keeps USD 135.00 target
TD Cowen reiterated its Buy rating and set a USD 135.00 price target on September 8, 2026, according to MarketBeat. The same report cited a Moderate Buy consensus and an average target of USD 119.50, both above the cited NYSE price at that time.
Next earnings date is October 20
Abbott is scheduled to report its next quarterly results on October 20, 2026, with an EPS estimate of USD 1.28, according to AltIndex. The date gives the guidance range a defined near-term checkpoint.
Abbott stock trades at EUR 88.79
At Lang & Schwarz, Abbott Laboratories stock was trading at EUR 88.79 on September 30, 2026, at 2:35 p.m. CEST, up 0.09 percent versus the prior close of EUR 88.71. The primary listing is NYSE, where the stock was last at USD 100.94 on September 29, 2026, at 3:59 p.m. ET, within a 52-week range of USD 81.97 to USD 135.45.
Abbott Laboratories stock facts
- Company: Abbott Laboratories
- ISIN: US0028241000
- Ticker: ABT
- Primary exchange: NYSE
- Price Lang & Schwarz (as of September 30, 2026, 2:35 p.m. CEST): EUR 88.79
- Change versus prior close: plus 0.09 percent
- Prior close Lang & Schwarz (September 29, 2026): EUR 88.71
- Market capitalization: USD 174.7 billion (as of September 30, 2026)
- 52-week range: USD 81.97-135.45 (as of September 30, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Index membership: S&P 500
- Next earnings date: October 20, 2026
